Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.280
-0.150 (-3.39%)
At close: Jul 20, 2026, 4:00 PM EDT
4.450
+0.170 (3.97%)
After-hours: Jul 20, 2026, 7:38 PM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $49.62 million as of July 20, 2026. Its market cap has increased by 46.14% in one year.
Market Cap
49.62M
Enterprise Value
24.17M
1-Year Change
46.14%
Ranking
Category
Stock Price
$4.28
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $49.62M, a decrease of -31.88%. That is a compound annual growth rate of -7.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 49.62M | -16.04% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 51.62M |
| Immutep | 51.45M |
| Filana Therapeutics | 51.21M |
| eXoZymes | 51.04M |
| INmune Bio | 50.51M |
| Instil Bio | 50.32M |
| aTyr Pharma | 49.99M |
| Mereo BioPharma Group | 49.50M |